| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 31.10.2002 (7851
dage). |
Ingen historik.
| Branche | | Forskning og eksperimentel udvikling indenfor bioteknologi (721100). |
| Sidst opdateret den 03.04.2013 og
angivet som gældende fra 01.12.2012 (4167
dage). |
| Historik | Start | Stop |
|---|
| Forskning og eksperimentel udvikling indenfor bioteknologi (721100) | 01.12.2012 | |
| Fremstilling af medicinske og dentale instrumenter samt udstyr hertil (325000) | 01.01.2008 | 30.11.2012 |
| Fremstilling af røntgenapparatur, tandlægeapparatur, respirationsapparater, ortopædiske artikler, pr (331090) | 31.10.2002 | 31.12.2007 |
| Revisionfravalgt | | false. |
| Sidst opdateret den 11.03.2015 og
angivet som gældende fra 31.10.2002 (7851
dage). |
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Navne | | PROXEON BIOSYSTEMS ApS. |
| Sidst opdateret den 23.02.2016 og
angivet som gældende fra 23.02.2016 (2988
dage). |
| Historik | Start | Stop |
|---|
| PROXEON BIOSYSTEMS ApS | 23.02.2016 | |
| PROXEON BIOSYSTEMS A/S | 22.01.2003 | 22.02.2016 |
| PROTANA ENGINEERING HOLDING A/S | 31.10.2002 | 21.01.2003 |
| Binavne | | PROTANA ENGINEERING ApS. |
| Sidst opdateret den 23.02.2016 og
angivet som gældende fra 23.02.2016 (2988
dage). |
| Historik | Start | Stop |
|---|
| PROTANA ENGINEERING ApS | 23.02.2016 | |
| PROXEON ApS | 23.02.2016 | |
| PROXEON BIOINFORMATICS ApS | 23.02.2016 | |
| PROXEON BIOSCIENCES ApS | 23.02.2016 | |
| PROTANA ENGINEERING A/S | 31.10.2002 | 22.02.2016 |
| PROXEON A/S | 31.10.2002 | 22.02.2016 |
| PROXEON BIOINFORMATICS A/S | 31.10.2002 | 22.02.2016 |
| PROXEON BIOSCIENCES A/S | 31.10.2002 | 22.02.2016 |
| Tegningsregel | | Selskabet tegnes af bestyrelsesformanden i forening med et bestyrelsesmedlem, af en direktør i forening med et bestyrelsesmedlem samt af den samlede bestyrelse. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 24.05.2011 (4724
dage). |
| Fortolkning
(3 tegningsmuligheder)
| | formanden + 1 bestyrelsesmedlem |
| 1 direktør + 1 bestyrelsesmedlem |
| bestyrelsen |
Ingen historik.
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:33771231
Beskrivelse af revisor:State Authorised Public Accounta
Virksomhedens regnskabsklasse:Reporting class B
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additionalrequirements applicable in Denmark. Our responsibilities under those standards and requirements arefurther described in the ”Auditor’s responsibilities for the audit of the Financial Statements” section of ourreport. We are independent of the Company in accordance with the International Ethics Standards Board forAccountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additionalethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities inaccordance with these requirements and the IESBA Code. We believe that the audit evidence we haveobtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):In our opinion, the Financial Statements give a true and fair view of the financial position of the Company a31 December 2022 and of the results of the Company´s operations for the financial year 1 January - 31December 2022 in accordance with the Danish Financial Statements Act. We have audited the Financial Statements of Proxeon Biosystems ApS for the financial year 1 January - 31December 2022, which comprise income statement, balance sheet, statement of changes in equity and notes,including a summary of significant accounting policies (”the Financial Statements”).
Udtalelse om ledelsesberetningen (revision):Management is responsible for Management’s Review. Our opinion on the Financial Statements døs not cover Management’s Review, and we do not express anyform of assurance conclusion thereon. In connection with our audit of the Financial Statements, our responsibility is to read Management’s Reviewand, in doing so, consider whether Management’s Review is materially inconsistent with the FinancialStatements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether Management’s Review provides the informationrequired under the Danish Financial Statements Act. Based on the work we have performed, in our view, Management’s Review is in accordance with the FinancialStatements and has been prepared in accordance with the requirements of the Danish Financial StatementsAct. We did not identify any material misstatement in Management’s Review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration